Aduro Biotech, OneMedForum SF Presenting Company, Announces $20 Million Financing
Aduro BioTech, a OneMedForum presenting company is engineering Listeria to treat Pancreatic Cancer and other infectious diseases.
Month: April 2011
New Software From iCAD Helps Doctors Diagnose Prostate Cancer
New software being used at Englewood Hospital and Medical Center should help detect prostate cancer earlier, eliminate unnecessary testing procedures and help form a treatment plan.
VisEn Medical Develops New Light Based Diagnostics
Technology that enables the fast and sensitive detection of biological and disease specific markers in live tissue is a major need in the diagnostic field. […]
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
Applied NeuroSolutions Identifies Protein Associated with Alzheimer’s
Applied NeuroSolutions is a specialty biopharmaceutical company that is developing unprecedented early diagnostic tests and therapeutics for Alzheimer’s disease. The company’s technological platform is based […]
Optomed Technology Enables Detailed Opthalmic Observation
Optomed is a medical devices company that has developed state of the art digital imaging systems for ophthalmologic (eye) analysis. The company’s latest development is […]
Receptor Logic Develops Improved Diagnostic Antibodies
Antibody based diagnostics and therapeutics represent a major medical advance as they respectively identify diseases with high specificity and preclude systemic side effects by recognizing […]
BiOptix Closes $9 Million Series B Funding
BiOptix, headquartered in Boulder, Colorado, seeks to expand the power of label-free technology with its groundbreaking Surface Plasmon-enhanced Common Path Interferometry (SPE) instrument, the ACCOLADE. […]
ThermoGenesis to Begin Sale of Novel Stem Cell Device in India
ThermoGenesis said its device, used in processing stem cells from bone marrow, got Indian marketing approval, sending its shares up as much as 8 percent.
Taris Biomedical Closes $18.3 Million Financing
Taris Biomedical completes an $18.3 million B round that the company says will support the clinical development of its bladder disorder treatment drug-device combination.